Ardent Health (NYSE:ARDT) FY Conference November 18, 2025 11:00 AM ET Company ParticipantsAlfred Lumsdaine - CFOMarty Bonick - President and CEOConference Call ParticipantsRaj Kumar - Healthcare Services AnalystRaj KumarAll right, so we're here at the top of the hour, so we're just going to get started. Welcome to Day One of the Stephens 2025 Annual Investment Conference, live and in person in Nashville. I'm Raj Kumar, Healthcare Services Analyst with Stevens. For our next panel, we have Ardent Health. Arde ...

Accessibility StatementSkip Navigation Awardees Focused on Smart Pump Integration, Safe Chemotherapy Handling, and Patient Partnership WILLOW GROVE, Pa., Nov. 18, 2025 /PRNewswire/ -- The Institute for Safe Medication Practices (ISMP) is proud to announce the 28th Annual Cheers Award winners, who have significantly advanced medication safety through innovation and collaboration. The awards ceremony will be held on Tuesday, December 9, 2025, at the House of Blues in Las Vegas. The annual ISMP Cheers Awards h ...

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. ("Auna†or the "Company†), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that EsSalud, Peru's Social Security System, has formally received the construction license for Torre Trecca, a high-rise outpatient treatment center that Auna will rebuild and, upon completion, operate on behalf of EsSalud as part of an existing public–private partnership ("PPP†). When completed, Torre Trecca is. ...

Recognizing the 50 top leaders using tech for business impact. Edited By Alex Knapp and Richard NievaReporting by Brit Morse and Alicia ParkDeputy Editor: Elisabeth BrierInthe past decade, the CIO role has evolved from a purely technical one into a remit that crosses a smorgasbord of disciplines that include everything from risk management to strategic transformation. The leaders below are showing how it's done in a world being remade by artificial intelligence. The pace of AI development has grown increasi ...

Core Insights - Astrana Health, Inc. (NASDAQ:ASTH) has received mixed opinions from analysts, with a Buy rating from Truist Financial and a lowered price target from TD Cowen [1][2] Financial Performance - For fiscal Q3 2025, Astrana Health reported a revenue growth of 99.71% year-over-year, reaching $956.05 million, which exceeded estimates by $3.22 million [2] - The company's EPS was $0.01, which fell short of the consensus estimate by $0.43 [2] Future Outlook - Management has lowered its full-year revenue guidance to a range of $3.1 billion to $3.18 billion, down from the previous range of $3.1 billion to $3.3 billion [3] - Adjusted EBITDA guidance was also reduced to a range of $200 million to $210 million, from the previous range of $215 million to $225 million [3] - The reduced outlook is attributed to anticipated headwinds in the Medicaid and exchange business [3][4] Analyst Commentary - Analyst Ryan Langston from TD Cowen noted that the cautious outlook reflects concerns regarding Medicaid and the value-based care (VBC) environment [4] - Astrana Health is characterized as a physician-centered, technology-powered healthcare company focused on delivering coordinated, high-quality care [4]

Company Overview - Surgery Partners, Inc. (NASDAQ:SGRY) operates surgical facilities across the United States, providing outpatient surgery, diagnostic imaging, and laboratory services, focusing on cost-effective surgical solutions [1] Price Targets and Analyst Ratings - Mizuho Securities set a price target of $22 for SGRY, indicating a potential upside of 44.74% from its current trading price of $15.20 [2] - Cantor Fitzgerald maintains an "overweight" rating with a price target of $36, while the Royal Bank of Canada has set a $31 target with an "outperform" rating [3] - Benchmark adjusted its price target for SGRY from $35 to $30, maintaining a "buy" rating, whereas Weiss Ratings reaffirmed a "sell (d-)" rating [4] Stock Performance and Trading Activity - SGRY's stock price has decreased to $15.06, a drop of 1.47% or $0.22, with fluctuations between $15.01 and $15.57 [2] - The stock has experienced a 52-week high of $26.16 and a low of $15.01, indicating its volatile nature [5] - There has been a significant surge in options trading activity, with a 498% increase in put options, suggesting investor uncertainty or hedging strategies [3][6] Market Capitalization and Trading Volume - The stock's market capitalization is approximately $1.95 billion, with a trading volume of 1,356,144 shares on the NASDAQ exchange [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Molina Healthcare, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Molina securities between February 5, 2025, and July 23, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant amounts for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Molina Healthcare failed to disclose several material adverse facts, including issues related to medical cost trend assumptions and the impact on financial guidance for fiscal year 2025 [5]. - Specific claims include a dislocation between premium rates and medical costs, reliance on limited service utilization for growth, and misleading positive statements about the company's business prospects [5].

Core Insights - Ardent Health, Inc. is under investigation by Levi & Korsinsky for potential violations of federal securities laws [1] - The company reported a $43 million reduction in revenue and a $54 million increase in professional liability reserves in its Q3 2025 financial results [2] - Following the financial disclosures, Ardent's stock experienced a significant decline during pre-market trading [3] Financial Performance - Ardent Health disclosed a $43 million decrease in revenue due to changes in accounting estimates regarding accounts receivable [2] - The company also announced a $54 million increase in professional liability reserves related to claims in New Mexico [2] Market Reaction - The stock price of Ardent Health fell significantly in pre-market trading on November 13, 2025, following the release of its financial results [3]

Core Insights - The company is focused on patient care, emphasizing positive outcomes in quality and safety for the year-to-date [2] - Employee engagement and satisfaction are improving, with a workforce of 315,000 serving 44 million patients last year [3] Company Performance - The company has reported positive trends in patient care outcomes, indicating effective efforts from clinical teams [2] - Retention and turnover reduction are prioritized, alongside workforce development initiatives like the Galen School of Nursing and physician residency programs [3]

PresentationAll right. Good morning. My name is Justin Lake. I cover health care services here at Wolfe Research. I appreciate you all being here, especially DaVita. We've got Joel Ackerman, the company's CFO. Joel, thanks for being with us today.Before I get into my list of questions here, I thought, Joel, I'd give you a minute to kind of give us your latest thoughts on the year for DaVita, what's gone right, what could have gone better? And maybe you can talk a little bit about your positioning for 2026.J ...